Trial Profile
An open-label, prospective, cohort study of adalimumab and etanercept in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 08 Nov 2016 New trial record